University of Canterbury Home
    • Admin
    UC Research Repository
    UC Library
    JavaScript is disabled for your browser. Some features of this site may not work without it.
    View Item 
    1. UC Home
    2. Library
    3. UC Research Repository
    4. Faculty of Science | Te Kaupeka Pūtaiao
    5. Science: Theses and Dissertations
    6. View Item
    1. UC Home
    2.  > 
    3. Library
    4.  > 
    5. UC Research Repository
    6.  > 
    7. Faculty of Science | Te Kaupeka Pūtaiao
    8.  > 
    9. Science: Theses and Dissertations
    10.  > 
    11. View Item

    Optimising the use of an EPID-based in-vivo dose verification system for 3DCRT breast treatments. (2019)

    Thumbnail
    View/Open
    Rajasekar, Abinaya_Master's Thesis.pdf (7.003Mb)
    Type of Content
    Theses / Dissertations
    UC Permalink
    http://hdl.handle.net/10092/16824
    http://dx.doi.org/10.26021/8202
    
    Thesis Discipline
    Medical Physics
    Degree Name
    Master of Science
    Publisher
    University of Canterbury
    Language
    English
    Collections
    • Science: Theses and Dissertations [4774]
    Authors
    Rajasekar, Abinaya
    show all
    Abstract

    Purpose Christchurch Hospital has implemented EPIgray, an EPID based in-vivo dosimetry (IVD) sys- tem for dosimetric verification of treatment. The current EPIgray clinical tolerance of ±5% has been set for all sites treated using 3D conformal radiation therapy (3DCRT). This project aims to optimise the use of EPIgray for treatment verification of 3DCRT breast treatments, by estab- lishing a site specific clinical tolerance, reducing false positive results and investigating causes of error.

    Methods A retrospective study was performed in which 30 previously treated 3DCRT breast patients were re-analysed within EPIgray with the current tolerance. EPID based IVD systems are susceptible to setup errors on treatment. Positional corrections in EPIgray were performed to identify groups of patients at increased risk of having setup errors on treatment, and the impact of these on the EPIgray result. For controlled tests to validate the findings of the ret- rospective study, a phantom representing breast and lung tissue was designed. The phantom was positioned for treatment with setup errors of known magnitude in all orthogonal planes to compare EPIgray reconstructed doses against other routinely used dosimeters. An uncertain- ties investigation was also conducted in which the uncertainties associated with the EPIgray reconstructed doses were determined specifically for the treatment parameters used for 3DCRT breast treatments.

    Results The retrospective study has revealed that right breast patients and large breast patients were more prone to setup errors than left breast patients and small breast patients. The phantom study revealed that EPIgray reported doses are in agreement with the delivered dose. Whilst the accuracy of EPIgray was determined to be systematically offset from other dosimeters, the results have indicated that EPIgray can be reliably used with appropriate tolerances. The re- sults of the uncertainties investigation have shown that the intervention clinical tolerance for 3DCRT breast treatments can be reduced to ±3.5% with the aim of detecting potential treat- ment errors whilst still accounting for inherent uncertainties associated with EPIgray and the uncertainties associated with the variations in treatment.

    Conclusions This project has clinically validated the use of EPIgray for treatment verification of 3DCRT breast treatments. A new intervention tolerance of ±3.5% was recommended for all 3DCRT breast patients. This tolerance is smaller than the current intervention tolerance of ±5.0% and would aid in the reduction of false results.

    Rights
    All Rights Reserved
    https://canterbury.libguides.com/rights/theses

    Related items

    Showing items related by title, author, creator and subject.

    • Optimising the use of EPIgray in-vivo dose verification for breast treatments 

      Rajasekar A; Moggre A; Cousins A; Marsh SH (2017)
    • Free propagation phase-contrast breast CT provides higher image quality than cone-beam breast-CT at low radiation doses: a feasibility study on human mastectomies 

      Pacilè S; Dullin C; Baran P; Tonutti M; Perske C; Fischer U; Albers J; Arfelli F; Dreossi D; Pavlov K; Maksimenko A; Mayo SC; Nesterets YI; Taba ST; Lewis S; Brennan PC; Gureyev TE; Tromba G; Wienbeck S (Springer Science and Business Media LLC, 2019)
      © 2019, The Author(s). In this study we demonstrate the first direct comparison between synchrotron x-ray propagation-based CT (PB-CT) and cone-beam breast-CT (CB-CT) on human mastectomy specimens (N = 12) including different ...
    • Free propagation phase-contrast breast CT provides higher image quality than cone-beam breast-CT at low radiation doses: a feasibility study on human mastectomies 

      Pacilè S; Dullin C; Baran P; Tonutti M; Perske C; Fischer U; Albers J; Arfelli F; Dreossi D; Maksimenko A; Mayo SC; Nesterets YI; Taba ST; Lewis S; Brennan PC; Gureyev TE; Tromba G; Wienbeck S; Pavlov, Konstantin (Springer Science and Business Media LLC, 2019)
      In this study we demonstrate the first direct comparison between synchrotron x-ray propagation-based CT (PB-CT) and cone-beam breast-CT (CB-CT) on human mastectomy specimens (N = 12) including different benign and malignant ...
    Advanced Search

    Browse

    All of the RepositoryCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThesis DisciplineThis CollectionBy Issue DateAuthorsTitlesSubjectsThesis Discipline

    Statistics

    View Usage Statistics
    • SUBMISSIONS
    • Research Outputs
    • UC Theses
    • CONTACTS
    • Send Feedback
    • +64 3 369 3853
    • ucresearchrepository@canterbury.ac.nz
    • ABOUT
    • UC Research Repository Guide
    • Copyright and Disclaimer
    • SUBMISSIONS
    • Research Outputs
    • UC Theses
    • CONTACTS
    • Send Feedback
    • +64 3 369 3853
    • ucresearchrepository@canterbury.ac.nz
    • ABOUT
    • UC Research Repository Guide
    • Copyright and Disclaimer